Manuel Pinto Coelho: Preventive Medicine, Scientific Overreach and the Weight of Evidence

The most persuasive medical overstatements are rarely invented from nothing. They usually begin with a fact that is genuinely important, then expand beyond what the evidence can support.

That pattern appears repeatedly in public statements by the Portuguese physician Manuel Pinto Coelho. His communication emphasises prevention, lifestyle, nutrition and scepticism toward conventional medical practice. Those themes are legitimate areas of debate. The difficulty is not that inflammation, diet, vitamin D or fasting are irrelevant. It is that several public claims move from those valid observations to conclusions that are much stronger.

The scientific question is therefore not whether every statement is simply “true” or “false”. It is where the evidential boundary lies.

Cholesterol and inflammation are not competing explanations

Pinto Coelho has publicly described cholesterol as a major distraction and framed inflammation as the more fundamental cardiovascular problem, with sugar presented as an important upstream driver.

The argument begins with a real observation. Atherosclerosis is an inflammatory disease. Immune signalling participates in plaque initiation, progression and rupture. Contemporary cardiovascular medicine does not dispute that.

But inflammation does not make LDL causally irrelevant.

The evidence linking LDL to atherosclerotic cardiovascular disease is unusually strong because several independent methods converge. Genetic variants that increase lifelong LDL exposure increase cardiovascular risk. Variants that lower LDL reduce risk. Prospective cohorts show dose-dependent associations, and randomized lipid-lowering trials reduce vascular events in relation to the magnitude and duration of LDL reduction.

The European Atherosclerosis Society has summarised this convergence across genetics, epidemiology, Mendelian randomisation and clinical trials and concluded that LDL is causal in atherosclerotic cardiovascular disease.

Inflammation and LDL therefore belong in the same causal system rather than in a contest for the title of “real cause”.

LDL retention in the arterial wall can initiate and sustain inflammatory processes. Inflammatory signalling can then influence plaque progression and instability. Describing cholesterol as a distraction because inflammation also matters removes one causal layer rather than improving the model.

Atherosclerosis is not made simpler by choosing one mechanism and deleting the others.

Criticism of statin prescribing is different from criticism of statins

There is a legitimate debate about who should receive statins, at what intensity and under what risk threshold.

Not every person with an elevated cholesterol value should automatically receive medication. Absolute cardiovascular risk, age, prior disease, diabetes, LDL concentration, familial hypercholesterolaemia, drug interactions, adverse effects and patient preferences all matter.

That is evidence-based prescribing.

It is not evidence that statins as a class are a failed medical idea.

Statins lower LDL by inhibiting HMG-CoA reductase. Large randomized trials and meta-analyses have shown reductions in major vascular events, particularly in secondary prevention and higher-risk primary prevention.

Current ESC/EAS guidance continues to recommend statins as first-line pharmacological therapy when lipid lowering is indicated.

That does not imply zero harm. Muscle symptoms, a small increase in diabetes risk in susceptible people, interactions and rare serious adverse events are all part of the clinical calculation.

The correct comparison is expected benefit against expected harm in a defined patient.

Replacing that calculation with “statins are overused, therefore statins are bad medicine” is an inferential leap.

Sugar can contribute to poor metabolic health without explaining most inflammation

The claim that sugar is a principal cause of inflammation and that inflammation then explains a very large share of chronic disease is another example of causal compression.

Excessive intake of sugar-sweetened beverages can contribute to obesity, type 2 diabetes, dental disease and cardiovascular risk. Diet affects inflammatory biology. Adipose dysfunction, insulin resistance and hepatic fat accumulation can also alter inflammatory signalling.

Those are legitimate concerns.

But “inflammation” is not one disease and sugar is not its universal cause.

Inflammatory processes can arise from infection, autoimmune disease, smoking, adiposity, tissue injury, ageing, sleep disturbance, chronic disease and many other exposures.

Controlled feeding studies also complicate the simple story. A systematic review and meta-analysis of intervention studies did not find a consistent generalized inflammatory effect from fructose compared with glucose or sucrose. Later work showed that the food source and energy context matter: sugar-sweetened beverages are not equivalent to whole fruit merely because both contain sugars.

This distinction is essential.

The scientifically defensible claim is that excessive added-sugar intake can contribute to adverse metabolic states and that those states can involve inflammation.

The much stronger claim that sugar is the principal inflammatory cause of most disease is not established.

Sunlight, vitamin D and cancer require a dose-response model

Pinto Coelho has also argued publicly that sunlight protects more against cancer than it causes, often connecting the argument to vitamin D.

Again, the starting point is real.

Ultraviolet B radiation stimulates cutaneous vitamin D synthesis, and vitamin D has important physiological roles. Outdoor activity also has health benefits unrelated to ultraviolet exposure itself.

But solar ultraviolet radiation is a known human carcinogen.

IARC has classified solar radiation as carcinogenic to humans, and WHO identifies ultraviolet radiation as the main environmental cause of skin cancers.

The correct model is therefore not “sun good” or “sun bad”. It is dose dependent.

Benefits and harms can coexist at different levels of exposure.

That matters because the broad claim that sunlight prevents more cancer than it causes requires a population-level causal comparison across skin cancer, other cancers, latitude, skin type, behaviour, vitamin D status and competing confounders. It cannot be established by pointing out that sunlight makes vitamin D.

Vitamin D deficiency can also be addressed through diet or supplementation in appropriate circumstances without reproducing the same ultraviolet exposure.

A true physiological benefit does not neutralise an established carcinogenic hazard.

Fasting can be useful without being “surgery without a scalpel”

Describing fasting as a form of surgery without a scalpel is rhetorically powerful because it suggests selectivity: harmful material is removed while healthy tissue is preserved.

Human metabolism is not that tidy.

Fasting changes insulin, glycogen use, lipolysis, fatty-acid oxidation and ketone production. Longer fasting can alter nutrient-sensing pathways associated with autophagy. Those are real physiological responses.

Intermittent fasting can also help some people reduce energy intake and body weight.

The problem is the metaphor.

Autophagy is intracellular turnover. It is not a general detoxification mechanism that selectively removes everything harmful from the body. Weight loss during fasting does not demonstrate that the body is performing an internal surgical procedure.

When intermittent fasting is compared directly with continuous energy restriction, differences in long-term weight and metabolic outcomes are often smaller than the rhetoric implies.

This does not make fasting ineffective. It means fasting should be evaluated as one dietary structure among alternatives rather than as a uniquely cleansing biological intervention.

Preventive medicine does not require opposition to evidence-based medicine

One of the recurring strengths in Pinto Coelho's public communication is the emphasis on prevention.

That principle is not controversial.

Smoking cessation, vaccination, exercise, healthy dietary patterns, blood-pressure control, diabetes prevention, lipid management and appropriate screening are all core preventive medicine.

The disagreement is not between prevention and conventional medicine.

It is between prevention grounded in evidence and prevention grounded in simplified causal stories.

There is no need to deny the causal role of LDL to promote exercise. There is no need to dismiss statins as a class to argue against indiscriminate prescribing. There is no need to deny the carcinogenicity of ultraviolet radiation to discuss vitamin D. There is no need to describe fasting as internal surgery to study its metabolic effects.

Preventive medicine becomes stronger when those rhetorical additions are removed.

The recurring pattern is reduction of a multivariable system to one dominant cause

The claims discussed here share a structure.

Atherosclerosis becomes inflammation.

Inflammation becomes sugar.

Cancer prevention becomes vitamin D.

Metabolic health becomes fasting.

Once one variable is made dominant, the corresponding intervention becomes obvious.

The appeal is understandable. Complex systems are difficult to communicate.

But human disease is rarely organised around one explanatory axis. Genetics, environment, behaviour, medication, age, tissue-specific mechanisms and time interact.

A useful scientific model often becomes less memorable as it becomes more accurate.

That is not a defect.

It is the cost of describing biology honestly.

Partial truth is more persuasive than obvious nonsense

This is why these claims deserve serious analysis.

Chronic inflammation matters.

Excess added sugar can be harmful.

Vitamin D matters.

Fasting changes metabolism.

Lifestyle matters enormously for long-term health.

All of those statements are defensible.

The problem appears when an unsupported conclusion is placed immediately after a supported premise.

A plausible mechanism becomes a universal explanation. A real risk factor becomes a distraction because another risk factor exists. A short-term metabolic response becomes a claim about long-term disease.

The scientific task is to identify the point at which the inference becomes stronger than the evidence.

Conclusion

The strongest criticism of overstated health communication is not that every claim is false.

It is that legitimate biological observations are repeatedly asked to carry more explanatory weight than they can support.

Inflammation is important, but LDL is not a distraction. Excess sugar can contribute to poor metabolic health, but it is not a universal explanation for chronic inflammation. Sunlight contributes to vitamin D synthesis, but ultraviolet radiation remains carcinogenic. Intermittent fasting can be useful without functioning as selective internal surgery. Statins can be prescribed badly while still having strong randomized evidence in appropriate patients.

That pattern is worth recognising because it extends far beyond one communicator.

Scientific misinformation often works best when the first half of the sentence is true.

---

References

1. NiT. Manuel Pinto Coelho: “O jejum é uma cirurgia sem bisturi”. 5 March 2026. https://www.nit.pt/fit/saude/manuel-pinto-coelho-o-jejum-e-uma-cirurgia-sem-bisturi

2. Expresso. Manuel Pinto Coelho: “O sol protege mais contra o cancro do que o provoca”. https://leitor.expresso.pt/semanario/semanario2324/html/revista-e/-e/manuel-pinto-coelho-o-sol-protege-mais-contra-o-cancro-do-que-o-provoca

3. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal. 2017;38:2459–2472. https://academic.oup.com/eurheartj/article/38/32/2459/3745109

4. European Society of Cardiology. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. https://www.escardio.org/communities/councils/cardiology-practice/education/cardiopractice/what-is-new-in-the-2025-focused-update-of-the-2019-esc-eas-guidelines-for-the-m/

5. Della Corte K, et al. Effect of Dietary Sugar Intake on Biomarkers of Subclinical Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2018;10:606. https://pubmed.ncbi.nlm.nih.gov/29757229/

6. Qi X, et al. Effect of Important Food Sources of Fructose-Containing Sugars on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Controlled Feeding Trials. 2022. https://pubmed.ncbi.nlm.nih.gov/36235639/

7. International Agency for Research on Cancer. Solar and Ultraviolet Radiation. IARC Monographs, Volume 55. https://publications.iarc.who.int/73

8. World Health Organization. Ultraviolet radiation. https://www.who.int/news-room/fact-sheets/detail/ultraviolet-radiation

---

This article evaluates publicly documented health claims and the evidence supporting or contradicting them. It does not assess motives, character or private clinical practice.